Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.03 Insider Own13.84% Shs Outstand54.64M Perf Week2.14%
Market Cap208.18M Forward P/E- EPS next Y-0.92 Insider Trans0.00% Shs Float47.08M Perf Month-11.81%
Income-39.35M PEG- EPS next Q-0.22 Inst Own79.06% Short Float10.40% Perf Quarter41.11%
Sales0.00M P/S- EPS this Y31.97% Inst Trans-2.67% Short Ratio5.19 Perf Half Y713.23%
Book/sh1.47 P/B2.60 EPS next Y-0.55% ROA-42.35% Short Interest4.89M Perf Year19.44%
Cash/sh1.90 P/C2.00 EPS next 5Y- ROE-71.82% 52W Range0.36 - 5.89 Perf YTD609.50%
Dividend Est.- P/FCF- EPS past 5Y-52.56% ROI-36.91% 52W High-35.31% Beta1.48
Dividend TTM- Quick Ratio46.22 Sales past 5Y0.00% Gross Margin- 52W Low949.59% ATR (14)0.34
Dividend Ex-Date- Current Ratio46.22 EPS Y/Y TTM74.66% Oper. Margin0.00% RSI (14)49.93 Volatility5.15% 10.72%
Employees29 Debt/Eq0.41 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.80
Option/ShortYes / Yes LT Debt/Eq0.41 EPS Q/Q68.71% Payout- Rel Volume0.47 Prev Close3.73
Sales Surprise- EPS Surprise-13.86% Sales Q/Q- EarningsMay 02 BMO Avg Volume943.76K Price3.81
SMA204.13% SMA50-9.12% SMA20084.82% Trades Volume439,840 Change2.14%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Stephens Overweight $8
Mar-01-24Initiated JMP Securities Mkt Outperform $7
May-30-23Upgrade SVB Securities Market Perform → Outperform $5 → $8
Dec-23-21Initiated H.C. Wainwright Buy $12
May-14-24 07:53AM
May-07-24 07:30AM
May-06-24 02:06PM
May-02-24 01:54PM
06:40AM Loading…
Apr-11-24 06:40AM
Apr-08-24 04:30PM
Mar-28-24 01:15PM
Mar-07-24 01:54PM
Mar-06-24 02:51PM
Mar-05-24 06:00PM
Mar-04-24 07:30AM
Feb-28-24 07:30AM
09:17AM Loading…
Feb-23-24 09:17AM
Feb-22-24 07:30AM
Jan-22-24 07:30AM
Jan-09-24 10:25AM
Jan-05-24 07:30AM
Nov-22-23 07:30AM
Nov-02-23 09:40AM
Sep-05-23 07:30AM
Aug-16-23 07:30AM
Aug-03-23 07:30AM
Jul-13-23 08:00AM
Jun-08-23 10:41PM
Jun-03-23 09:00AM
06:54AM Loading…
May-19-23 06:54AM
May-15-23 07:30AM
Apr-26-23 04:05PM
Apr-17-23 10:15AM
Mar-23-23 09:40AM
Mar-14-23 04:30PM
Mar-09-23 07:30AM
Mar-01-23 07:00AM
Feb-08-23 07:00AM
Jan-09-23 07:30AM
Jan-06-23 08:15AM
Nov-30-22 07:30AM
Nov-03-22 07:30AM
Aug-12-22 09:30AM
Aug-04-22 07:30AM
Aug-03-22 08:00AM
Jul-28-22 08:50AM
Jul-14-22 08:45AM
Jun-01-22 07:30AM
May-26-22 05:05PM
May-25-22 07:30AM
May-05-22 07:30AM
Apr-27-22 10:05AM
Mar-24-22 01:12PM
Mar-14-22 07:00AM
Mar-03-22 07:30AM
Mar-01-22 07:00AM
Jan-10-22 07:00AM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Dec-16-21 09:14AM
Nov-18-21 08:00AM
Nov-12-21 07:30AM
Oct-20-21 07:00AM
Oct-14-21 07:00AM
Sep-25-21 09:52AM
Sep-07-21 07:00AM
Aug-12-21 04:05PM
Aug-04-21 07:00AM
Jun-24-21 08:44PM
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm's program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.